Cohen Capital Management’s Chemours CC Stock Holding History

Cohen Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,000	Closed	-$38K	–	160
2017 Q1	$38K	Buy	+1,000	New	+$30.1K	0.01%	181

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cohen Capital Management's CC Position: Q2 2017 in Review

Cohen Capital Management sold out of Chemours (CC) in Q2 2017, closing a stake of 1,000 shares — an estimated $38K sold.

Cohen Capital Management first reported a position in CC in Q1 2017 and held it in 1 quarter. The position peaked at $38K in Q1 2017. 462 funds tracked by Wall St. Rank hold CC as of Q2 2017.

Cohen Capital Management reported no remaining Chemours position as of Q2 2017 after selling out during the quarter.
Cohen Capital Management sold 1,000 Chemours shares in Q2 2017, an estimated $38K.
Cohen Capital Management first reported a position in Chemours in Q1 2017 and held it in 1 quarter.
Cohen Capital Management's Chemours position peaked at $38K in Q1 2017.
462 funds tracked by Wall St. Rank held Chemours as of Q2 2017.

Based on Cohen Capital Management's 13F filing for Q2 2017, filed 12 Jul 2017.